Literature DB >> 6970781

Distribution of t lymphocyte subsets in the human bone marrow and thymus: an analysis with monoclonal antibodies.

G Janossy, N Tidman, E S Papageorgiou, P C Kung, G Goldstein.   

Abstract

A panel of reagents (OKT1, 3, 4, 6, 8, and 11) detects differentiation antigens expressed exclusively on HuTLA+ T lymphoid cells but absent on bone marrow precursors, such as terminal deoxynucleotidyl transferase- (TdT) positive cells, immature myeloblasts, and other myeloid/erythroid cell types. In the bone marrow no transitional forms could be detected between TdT+ and T cells. The BM T cells showed mostly the suppressor/cytotoxic phenotype (OKT8+) with only a few T cells of inducer type (OKT4+). Thymocyte heterogeneity was also analyzed directly in tissue sections and in double labeling assays in combination with TdT staining, a marker for cortical thymocytes. Many large thymic blasts (in fetal and infant thymus) showed reactivity with OKT11--a pan-T reagent, but had only weak or negligible activity with the other antibodies. Cortical thymocytes reacted strongly with OKT11, 6, 4, and 8, whereas medullary cells reacted with OKT11, 3, 4 (majority) and 8 (minority). Thus, the reactivity with these antibodies is generated in the thymus at various stages of differentiation. In contrast, OKT10 (an anti-"precursor cell" reagent) reacted not only with thymocytes but also with TdT+ BM precursors, myeloblasts, and BM B lymphocytes although it was unreactive with mature peripheral lymphoid and maturing myelo/erythroid cells.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6970781

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  61 in total

1.  Antibodies to normal human colon membranes: preparation, characterization and tissue distribution.

Authors:  R J Nicholls; J Southgate; L K Trejdosiewicz
Journal:  Histochem J       Date:  1985-06

Review 2.  Ontogeny of the human thymus during fetal development.

Authors:  D F Lobach; B F Haynes
Journal:  J Clin Immunol       Date:  1987-03       Impact factor: 8.317

3.  Lymphocyte populations in autopsy bone marrow sections from recipients of allogeneic marrow and non-transplant sudden death cases.

Authors:  S A Dilly; C J Jagger; J P Sloane
Journal:  Clin Exp Immunol       Date:  1990-07       Impact factor: 4.330

4.  The role of the thymus in multiple sclerosis.

Authors:  V D'Andrea; G Meco; F Corvese; P F Baselice; V Ambrogi
Journal:  Ital J Neurol Sci       Date:  1989-02

5.  Immature T lymphocytes after injury characterized by morphology and phenotypic markers.

Authors:  J J Wood; J B O'Mahony; M L Rodrick; J A Mannick
Journal:  Ann Surg       Date:  1987-11       Impact factor: 12.969

6.  Localization and characterization of T-cell subpopulations and natural killer cells (HNK 1+ cells) in the human tonsilla palatina. An ultrastructural-immunocytochemical study.

Authors:  B von Gaudecker; U Pfingsten; H K Müller-Hermelink
Journal:  Cell Tissue Res       Date:  1984       Impact factor: 5.249

7.  Establishment of a monoclonal antibody to plasma cells: a comparison with CD38 and PCA-1.

Authors:  H Hata; H Matsuzaki; F Matsuno; T Sonoki; S Takemoto; N Kuribayashi; A Nagasaki; K Takatsuki
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

8.  Prenatal diagnosis of three cases of severe combined immunodeficiency: severe T cell deficiency during the first half of gestation in fetuses with adenosine deaminase deficiency.

Authors:  D C Linch; R J Levinsky; C H Rodeck; K A Maclennan; H A Simmonds
Journal:  Clin Exp Immunol       Date:  1984-05       Impact factor: 4.330

9.  Characterization of early lymphoid precursor cells in the human fetus using monoclonal antibodies and anti-terminal deoxynucleotidyl transferase.

Authors:  G E Asma; R L van den Bergh; J M Vossen
Journal:  Clin Exp Immunol       Date:  1986-05       Impact factor: 4.330

10.  Subset markers of CD8(+) cells and their relation to enhanced cytotoxic T-cell activity during human immunodeficiency virus infection.

Authors:  G Vanham; L Kestens; G Penne; C Goilav; P Gigase; R Colebunders; M Vandenbruaene; J Goeman; G van der Groen; J L Ceuppens
Journal:  J Clin Immunol       Date:  1991-11       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.